Apogee Therapeutics, Inc. (APGE)

Typically moves ±6.76% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-11 ESTIMATED

Across 12 earnings reports since Aug 28, 2023, Apogee Therapeutics, Inc. (APGE) has a clear post-earnings pattern. It moves ±6.76% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +42.07% (Mar 05, 2024) and its largest decline was -5.14% (Nov 12, 2024). The next earnings report is predicted for 2026-11-11 (estimated).

Earnings reactions

How APGE moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.76%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 10, 2026	☀ PRE	-0.13%	open_in_new
May 11, 2026	☀ PRE	+1.81%	open_in_new
Nov 10, 2025	☀ PRE	+3.77%	open_in_new
Aug 11, 2025	☀ PRE	-2.09%	open_in_new
May 12, 2025	☀ PRE	+6.14%	open_in_new
Mar 03, 2025	☀ PRE	-0.16%	open_in_new
Nov 12, 2024	☀ PRE	-5.14%	open_in_new
Aug 12, 2024	☀ PRE	+9.78%	open_in_new
May 13, 2024	☀ PRE	-0.92%	open_in_new
Mar 05, 2024	☀ PRE	+42.07%	open_in_new
Nov 13, 2023	☀ PRE	+7.32%	open_in_new
Aug 28, 2023	☀ PRE	-1.77%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.76%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 28 →

Funds holding

$2083235014

Total value held

Buying

22 added · 6 reduced

Blackrock, Inc.

$730948292 +34.79%

State Street Corp

$304979428 +6.23%

Goldman Sachs Group Inc

$224757151 +159.48%

Janus Henderson Group Plc

$198808884 NEW BUY

Morgan Stanley

$188699836 +138.93%

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13D/A	20260908	open_in_new SEC.gov
25-NSE	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov
4	20260903	open_in_new SEC.gov

Frequently asked about APGE earnings

When does Apogee Therapeutics, Inc. report earnings next? expand_more

Apogee Therapeutics, Inc. (APGE)'s next earnings date is estimated for 2026-11-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does APGE stock move after earnings? expand_more

Over 12 reports, APGE has moved an average of ±6.76% the session after earnings, closing higher 50.0% of the time.

What was APGE's biggest post-earnings move? expand_more

APGE's largest post-earnings gain on record was +42.07% on Mar 05, 2024, and its largest decline was -5.14% on Nov 12, 2024.

Where can I find Apogee Therapeutics, Inc.'s SEC filings? expand_more

All of Apogee Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.